Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 12/06/2024
Closing price: 92.13
Support price level: | $89.45 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 64.9 |
Beta | 0.45 |
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$63.15 | $97.90 | 86.1% |
200 day | 50 day | 20 day | 10 day |
$76.03 | $89.02 | $91.82 | $92.06 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
26.0% | 22.8% | 26.2% | 25.5% |
- 7.1% in the next week.
- 14.4% in the next month.
- 48.1% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks